Soria, Anna; Calvo, Mariona; Casas, Meritxell; Vidales, Zara; Muñoz-Martínez, Sergio; Sapena, Victor; Puigvehí, Marc; Canillas, Lidia; Guardeño, Raquel; Gallego, Adolfo; Mínguez, Beatriz; Horta, Diana; Clos, Ariadna; Montoliu, Silvia; Roget, Mercè; Reig, María; Vergara, Mercè
(Frontiers, 2022)
Introduction: the first-line treatment for advanced hepatocellular carcinoma (HCC) is atezolizumab plus bevacizumab, but its availability is not universal and elderly patients are underrepresented in clinical trials. There ...
